BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 29411426)

  • 1. Integrating eQTL data with GWAS summary statistics in pathway-based analysis with application to schizophrenia.
    Wu C; Pan W
    Genet Epidemiol; 2018 Apr; 42(3):303-316. PubMed ID: 29411426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A fast and powerful eQTL weighted method to detect genes associated with complex trait using GWAS summary data.
    Zhang J; Xie S; Gonzales S; Liu J; Wang X
    Genet Epidemiol; 2020 Sep; 44(6):550-563. PubMed ID: 32350919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How powerful are summary-based methods for identifying expression-trait associations under different genetic architectures?
    Veturi Y; Ritchie MD
    Pac Symp Biocomput; 2018; 23():228-239. PubMed ID: 29218884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of Enhancer-Promoter Interactions with GWAS Summary Results Identifies Novel Schizophrenia-Associated Genes and Pathways.
    Wu C; Pan W
    Genetics; 2018 Jul; 209(3):699-709. PubMed ID: 29728367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian genome-wide TWAS with reference transcriptomic data of brain and blood tissues identified 141 risk genes for Alzheimer's disease dementia.
    Guo S; Yang J
    Alzheimers Res Ther; 2024 Jun; 16(1):120. PubMed ID: 38824563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Powerful Framework for Integrating eQTL and GWAS Summary Data.
    Xu Z; Wu C; Wei P; Pan W
    Genetics; 2017 Nov; 207(3):893-902. PubMed ID: 28893853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statistical power of transcriptome-wide association studies.
    He R; Xue H; Pan W;
    Genet Epidemiol; 2022 Dec; 46(8):572-588. PubMed ID: 35766062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leveraging expression from multiple tissues using sparse canonical correlation analysis and aggregate tests improves the power of transcriptome-wide association studies.
    Feng H; Mancuso N; Gusev A; Majumdar A; Major M; Pasaniuc B; Kraft P
    PLoS Genet; 2021 Apr; 17(4):e1008973. PubMed ID: 33831007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene-based association tests using GWAS summary statistics and incorporating eQTL.
    Cao X; Wang X; Zhang S; Sha Q
    Sci Rep; 2022 Mar; 12(1):3553. PubMed ID: 35241742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian Genome-wide TWAS Method to Leverage both cis- and trans-eQTL Information through Summary Statistics.
    Luningham JM; Chen J; Tang S; De Jager PL; Bennett DA; Buchman AS; Yang J
    Am J Hum Genet; 2020 Oct; 107(4):714-726. PubMed ID: 32961112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JEPEG: a summary statistics based tool for gene-level joint testing of functional variants.
    Lee D; Williamson VS; Bigdeli TB; Riley BP; Fanous AH; Vladimirov VI; Bacanu SA
    Bioinformatics; 2015 Apr; 31(8):1176-82. PubMed ID: 25505091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subset-based method for cross-tissue transcriptome-wide association studies improves power and interpretability.
    Guo X; Chatterjee N; Dutta D
    HGG Adv; 2024 Apr; 5(2):100283. PubMed ID: 38491773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide association study followed by trans-ancestry meta-analysis identify 17 new risk loci for schizophrenia.
    Liu J; Li S; Li X; Li W; Yang Y; Guo S; Lv L; Xiao X; Yao YG; Guan F; Li M; Luo XJ
    BMC Med; 2021 Aug; 19(1):177. PubMed ID: 34380480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. iFunMed: Integrative functional mediation analysis of GWAS and eQTL studies.
    Rojo C; Zhang Q; Keleş S
    Genet Epidemiol; 2019 Oct; 43(7):742-760. PubMed ID: 31328826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. nMAGMA: a network-enhanced method for inferring risk genes from GWAS summary statistics and its application to schizophrenia.
    Yang A; Chen J; Zhao XM
    Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33230537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Variance-Component TWAS method for studying complex human diseases with applications to Alzheimer's dementia.
    Tang S; Buchman AS; De Jager PL; Bennett DA; Epstein MP; Yang J
    PLoS Genet; 2021 Apr; 17(4):e1009482. PubMed ID: 33798195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SUMMIT-FA: a new resource for improved transcriptome imputation using functional annotations.
    Melton HJ; Zhang Z; Wu C
    Hum Mol Genet; 2024 Mar; 33(7):624-635. PubMed ID: 38129112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial vezatin and its association with endometriosis risk.
    Holdsworth-Carson SJ; Fung JN; Luong HT; Sapkota Y; Bowdler LM; Wallace L; Teh WT; Powell JE; Girling JE; Healey M; Montgomery GW; Rogers PA
    Hum Reprod; 2016 May; 31(5):999-1013. PubMed ID: 27005890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of multi-trait associations using pathway-based analysis of GWAS summary statistics.
    Pei G; Sun H; Dai Y; Liu X; Zhao Z; Jia P
    BMC Genomics; 2019 Feb; 20(Suppl 1):79. PubMed ID: 30712509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leveraging existing GWAS summary data of genetically correlated and uncorrelated traits to improve power for a new GWAS.
    Xue H; Wu C; Pan W
    Genet Epidemiol; 2020 Oct; 44(7):717-732. PubMed ID: 32677173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.